Trials / Completed
CompletedNCT03727100
Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults
A Prospective, Multicenter, Randomized, Double-Blinded, Sham-Control Study to Evaluate the Efficacy and Safety of Clonidine Micropellets for the Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 207 (actual)
- Sponsor
- Sollis Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and effectiveness of a new pain medication in development, clonidine micropellet. Participants will receive a single injection of either clonidine micropellet or sham injection for the treatment of low back and leg pain from sciatica.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Clonidine Micropellets | Injection |
| OTHER | Sham | Injection |
Timeline
- Start date
- 2018-10-16
- Primary completion
- 2020-03-05
- Completion
- 2020-07-18
- First posted
- 2018-11-01
- Last updated
- 2023-10-06
Locations
33 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03727100. Inclusion in this directory is not an endorsement.